<?xml version="1.0"?>
<presentation title="01 Yoshiki Hirooka" width="960.0000000" height="540.0000000" thmbWidth="78.0000000" thmbHeight="44.0000000" frameRate="24.0000000" looping="0" startingSlideShow="" pptVersion="2010" type="compound" hasExternalAudio="0" uid="{6D1FF0D1-10D6-49E4-89F0-DF8A386735CF}">
	<presenters>
		<presenter name="Yoshiki Hirooka" title="Japan" email="" web="" phone="" photoAssetId="">
			<bio>Contrast-enhanced EUS and EUS elasticity
imaging in the diagnosis of pancreatic solid
masses</bio>
		</presenter>
	</presenters>
	<references/>
	<soundAssets>
		<soundAsset id="sndAsset0" src="sound1.mp3" embedded="0" size="391359" duration="13977"/>
		<soundAsset id="sndAsset1" src="sound2.mp3" embedded="0" size="237759" duration="8491"/>
		<soundAsset id="sndAsset2" src="sound3.mp3" embedded="0" size="190948" duration="6819"/>
		<soundAsset id="sndAsset3" src="sound4.mp3" embedded="0" size="939199" duration="33542"/>
		<soundAsset id="sndAsset4" src="sound5.mp3" embedded="0" size="418422" duration="14943"/>
		<soundAsset id="sndAsset5" src="sound6.mp3" embedded="0" size="359176" duration="12827"/>
		<soundAsset id="sndAsset6" src="sound7.mp3" embedded="0" size="511314" duration="18261"/>
		<soundAsset id="sndAsset7" src="sound8.mp3" embedded="0" size="887999" duration="31714"/>
		<soundAsset id="sndAsset8" src="sound9.mp3" embedded="0" size="414034" duration="14786"/>
		<soundAsset id="sndAsset9" src="sound10.mp3" embedded="0" size="532525" duration="19018"/>
		<soundAsset id="sndAsset10" src="sound11.mp3" embedded="0" size="710994" duration="25392"/>
		<soundAsset id="sndAsset11" src="sound12.mp3" embedded="0" size="573485" duration="20481"/>
		<soundAsset id="sndAsset12" src="sound13.mp3" embedded="0" size="738056" duration="26359"/>
		<soundAsset id="sndAsset13" src="sound14.mp3" embedded="0" size="710994" duration="25392"/>
		<soundAsset id="sndAsset14" src="sound15.mp3" embedded="0" size="400868" duration="14316"/>
		<soundAsset id="sndAsset15" src="sound16.mp3" embedded="0" size="926034" duration="33072"/>
		<soundAsset id="sndAsset16" src="sound17.mp3" embedded="0" size="175588" duration="6271"/>
		<soundAsset id="sndAsset17" src="sound18.mp3" embedded="0" size="316022" duration="11286"/>
		<soundAsset id="sndAsset18" src="sound19.mp3" embedded="0" size="708068" duration="25288"/>
		<soundAsset id="sndAsset19" src="sound20.mp3" embedded="0" size="1646491" duration="58803"/>
		<soundAsset id="sndAsset20" src="sound21.mp3" embedded="0" size="694171" duration="24791"/>
		<soundAsset id="sndAsset21" src="sound22.mp3" embedded="0" size="259702" duration="9275"/>
		<soundAsset id="sndAsset22" src="sound23.mp3" embedded="0" size="430856" duration="15387"/>
		<soundAsset id="sndAsset23" src="sound24.mp3" embedded="0" size="329188" duration="11756"/>
		<soundAsset id="sndAsset24" src="sound25.mp3" embedded="0" size="577874" duration="20638"/>
		<soundAsset id="sndAsset25" src="sound26.mp3" embedded="0" size="453531" duration="16197"/>
		<soundAsset id="sndAsset26" src="sound27.mp3" embedded="0" size="359908" duration="12853"/>
		<soundAsset id="sndAsset27" src="sound28.mp3" embedded="0" size="606399" duration="21657"/>
		<soundAsset id="sndAsset28" src="sound29.mp3" embedded="0" size="275062" duration="9823"/>
		<soundAsset id="sndAsset29" src="sound30.mp3" embedded="0" size="657599" duration="23485"/>
		<soundAsset id="sndAsset30" src="sound31.mp3" embedded="0" size="580068" duration="20716"/>
	</soundAssets>
	<sharedAssetsLibrary src="assets.swf"/>
	<graphicAssets>
		<graphicAsset id="imgAsset0" src="thmb1.swf" embedded="0"/>
		<graphicAsset id="imgAsset1" src="thmb2.swf" embedded="0"/>
		<graphicAsset id="imgAsset2" src="thmb3.swf" embedded="0"/>
		<graphicAsset id="imgAsset3" src="thmb4.swf" embedded="0"/>
		<graphicAsset id="imgAsset4" src="thmb5.swf" embedded="0"/>
		<graphicAsset id="imgAsset5" src="thmb6.swf" embedded="0"/>
		<graphicAsset id="imgAsset6" src="thmb7.swf" embedded="0"/>
		<graphicAsset id="imgAsset7" src="thmb8.swf" embedded="0"/>
		<graphicAsset id="imgAsset8" src="thmb9.swf" embedded="0"/>
		<graphicAsset id="imgAsset9" src="thmb10.swf" embedded="0"/>
		<graphicAsset id="imgAsset10" src="thmb11.swf" embedded="0"/>
		<graphicAsset id="imgAsset11" src="thmb12.swf" embedded="0"/>
		<graphicAsset id="imgAsset12" src="thmb13.swf" embedded="0"/>
		<graphicAsset id="imgAsset13" src="thmb14.swf" embedded="0"/>
		<graphicAsset id="imgAsset14" src="thmb15.swf" embedded="0"/>
		<graphicAsset id="imgAsset15" src="thmb16.swf" embedded="0"/>
		<graphicAsset id="imgAsset16" src="thmb17.swf" embedded="0"/>
		<graphicAsset id="imgAsset17" src="thmb18.swf" embedded="0"/>
		<graphicAsset id="imgAsset18" src="thmb19.swf" embedded="0"/>
		<graphicAsset id="imgAsset19" src="thmb20.swf" embedded="0"/>
		<graphicAsset id="imgAsset20" src="thmb21.swf" embedded="0"/>
		<graphicAsset id="imgAsset21" src="thmb22.swf" embedded="0"/>
		<graphicAsset id="imgAsset22" src="thmb23.swf" embedded="0"/>
		<graphicAsset id="imgAsset23" src="thmb24.swf" embedded="0"/>
		<graphicAsset id="imgAsset24" src="thmb25.swf" embedded="0"/>
		<graphicAsset id="imgAsset25" src="thmb26.swf" embedded="0"/>
		<graphicAsset id="imgAsset26" src="thmb27.swf" embedded="0"/>
		<graphicAsset id="imgAsset27" src="thmb28.swf" embedded="0"/>
		<graphicAsset id="imgAsset28" src="thmb29.swf" embedded="0"/>
		<graphicAsset id="imgAsset29" src="thmb30.swf" embedded="0"/>
		<graphicAsset id="imgAsset30" src="thmb31.swf" embedded="0"/>
	</graphicAssets>
	<backgroundSound soundAssetId="" looping="0" volume="1.0000000"/>
	<narration>
		<audioTracks>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset0">
				<startTimestamp slideIndex="0" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="0" stepIndex="0" timeOffset="13.9469995"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset1">
				<startTimestamp slideIndex="1" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="1" stepIndex="0" timeOffset="8.4399996"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset2">
				<startTimestamp slideIndex="2" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="2" stepIndex="0" timeOffset="6.7700000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset3">
				<startTimestamp slideIndex="3" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="3" stepIndex="0" timeOffset="33.5000000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset4">
				<startTimestamp slideIndex="4" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="4" stepIndex="0" timeOffset="14.9150000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset5">
				<startTimestamp slideIndex="5" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="5" stepIndex="0" timeOffset="12.7790000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset6">
				<startTimestamp slideIndex="6" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="6" stepIndex="0" timeOffset="18.2180000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset7">
				<startTimestamp slideIndex="7" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="7" stepIndex="0" timeOffset="31.6650000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset8">
				<startTimestamp slideIndex="8" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="8" stepIndex="0" timeOffset="14.7480000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset9">
				<startTimestamp slideIndex="9" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="9" stepIndex="0" timeOffset="18.9860000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset10">
				<startTimestamp slideIndex="10" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="10" stepIndex="0" timeOffset="25.3590000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset11">
				<startTimestamp slideIndex="11" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="11" stepIndex="0" timeOffset="20.4500000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset12">
				<startTimestamp slideIndex="12" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="12" stepIndex="0" timeOffset="26.3260000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset13">
				<startTimestamp slideIndex="13" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="13" stepIndex="0" timeOffset="25.3590000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset14">
				<startTimestamp slideIndex="14" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="14" stepIndex="0" timeOffset="14.2799997"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset15">
				<startTimestamp slideIndex="15" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="15" stepIndex="0" timeOffset="33.0299988"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset16">
				<startTimestamp slideIndex="16" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="16" stepIndex="0" timeOffset="6.2399998"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset17">
				<startTimestamp slideIndex="17" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="17" stepIndex="0" timeOffset="11.2449999"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset18">
				<startTimestamp slideIndex="18" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="18" stepIndex="0" timeOffset="25.2590000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset19">
				<startTimestamp slideIndex="19" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="19" stepIndex="0" timeOffset="58.7590000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset20">
				<startTimestamp slideIndex="20" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="20" stepIndex="0" timeOffset="24.7580000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset21">
				<startTimestamp slideIndex="21" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="21" stepIndex="0" timeOffset="9.2399998"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset22">
				<startTimestamp slideIndex="22" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="22" stepIndex="0" timeOffset="15.3490000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset23">
				<startTimestamp slideIndex="23" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="23" stepIndex="0" timeOffset="11.7100000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset24">
				<startTimestamp slideIndex="24" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="24" stepIndex="0" timeOffset="20.5869999"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset25">
				<startTimestamp slideIndex="25" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="25" stepIndex="0" timeOffset="16.1490000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset26">
				<startTimestamp slideIndex="26" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="26" stepIndex="0" timeOffset="12.8100000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset27">
				<startTimestamp slideIndex="27" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="27" stepIndex="0" timeOffset="21.6200000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset28">
				<startTimestamp slideIndex="28" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="28" stepIndex="0" timeOffset="9.7760000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset29">
				<startTimestamp slideIndex="29" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="29" stepIndex="0" timeOffset="23.4570000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset30">
				<startTimestamp slideIndex="30" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="30" stepIndex="0" timeOffset="20.6870000"/>
			</audioTrack>
		</audioTracks>
	</narration>
	<settings>
		<navigation>
			<keyboard enabled="1">
				<actions>
					<action name="playPause">
						<shortcut code="32" control="0" shift="0"/>
					</action>
					<action name="nextSlide">
						<shortcut code="34" control="0" shift="0"/>
					</action>
					<action name="previousSlide">
						<shortcut code="33" control="0" shift="0"/>
					</action>
					<action name="nextStep">
						<shortcut code="13" control="0" shift="0"/>
					</action>
					<action name="previousStep">
						<shortcut code="13" control="0" shift="1"/>
					</action>
					<action name="firstSlide">
						<shortcut code="36" control="1" shift="0"/>
					</action>
					<action name="lastSlide">
						<shortcut code="35" control="1" shift="0"/>
					</action>
					<action name="lastViewedSlide">
						<shortcut code="8" control="0" shift="0"/>
					</action>
					<action name="slideStart">
						<shortcut code="36" control="0" shift="0"/>
					</action>
					<action name="slideEnd">
						<shortcut code="35" control="0" shift="0"/>
					</action>
					<action name="seekForward">
						<shortcut code="39" control="0" shift="0"/>
					</action>
					<action name="seekBackward">
						<shortcut code="37" control="0" shift="0"/>
					</action>
					<action name="volumeUp">
						<shortcut code="38" control="0" shift="0"/>
					</action>
					<action name="volumeDown">
						<shortcut code="40" control="0" shift="0"/>
					</action>
					<action name="toggleFullscreen">
						<shortcut code="70" control="1" shift="0"/>
					</action>
				</actions>
			</keyboard>
			<mouse enabled="1" target="step"/>
			<gesture zoom="1"/>
		</navigation>
		<skin>
			<colorSettings>
				<color id="button.content.normal">#FFFFFF</color>
				<color id="button.content.over">#FFFFFF</color>
				<color id="button.face.normal">#777777</color>
				<color id="button.face.over">#575757</color>
				<color id="companyLogo.background">#FFFFFF</color>
				<color id="hyperlink">#097CE7</color>
				<color id="listItem.face.over">#E8E8E8</color>
				<color id="listItem.face.pressed">#6E6E6E</color>
				<color id="listItem.label.over">#000000</color>
				<color id="listItem.label.pressed">#FFFFFF</color>
				<color id="listItem.label.visited">#A1A1A1</color>
				<color id="page.background">#8A8A8A</color>
				<color id="panel.background">#F7F7F7</color>
				<color id="panel.text">#323232</color>
				<color id="player.background">#D4D4D4</color>
				<color id="popup.background">#FFFFFF</color>
				<color id="progress.background">#6E6E6E</color>
				<color id="progress.loading">#D0D0D0</color>
				<color id="progress.playback">#A1A1A1</color>
				<color id="text">#4D4D4D</color>
			</colorSettings>
			<controlPanelSettings>
				<visible>true</visible>
				<showOutline>false</showOutline>
				<showPlayPause>true</showPlayPause>
				<showRewind>true</showRewind>
				<showVolumeControl>true</showVolumeControl>
				<showCCButton>false</showCCButton>
				<showPrevButton>true</showPrevButton>
				<showNextButton>true</showNextButton>
				<showSlideOnlyButton>true</showSlideOnlyButton>
				<progressBar>
					<visible>true</visible>
					<enabled>true</enabled>
					<showLabels>true</showLabels>
					<mode>slideTimeline</mode>
				</progressBar>
				<navigationMode>bySlides</navigationMode>
			</controlPanelSettings>
			<titlePanelSettings>
				<showLogo>false</showLogo>
				<visible>true</visible>
				<buttons>
					<button type="attachments" visible="false"/>
					<button type="presenterInfo" visible="false"/>
					<button type="markerTools" visible="true"/>
					<button type="notes" visible="false"/>
					<button type="outline" visible="false"/>
				</buttons>
			</titlePanelSettings>
			<outlinePanelSettings>
				<numberEntries>true</numberEntries>
				<highlightViewedEntries>true</highlightViewedEntries>
				<thumbnails>true</thumbnails>
				<search>true</search>
				<multilevel>true</multilevel>
			</outlinePanelSettings>
			<sidePanelSettings>
				<showAtLeft>true</showAtLeft>
				<showLogo>false</showLogo>
				<showPresenterInfo>true</showPresenterInfo>
				<showPresenterVideo>false</showPresenterVideo>
				<visible>true</visible>
				<tabsPanel>
					<showOutline>true</showOutline>
					<showNotes>false</showNotes>
				</tabsPanel>
			</sidePanelSettings>
		</skin>
		<appearance fullScreen="1" showSlidePreloader="1"/>
		<playback autoStart="1" syncWithVideoNarration="1" enableVideoControl="1" resumePresentationPlayback="always"/>
	</settings>
	<slides embedded="0">
		<slide index="0" title="" titleNormalized="" src="slide1.swf" size="356233" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset0" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="13.9459995"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="1" title="Contrast-enhanced EUS and EUS elasticity imaging in the diagnosis of pancreatic solid masses" titleNormalized="contrast-enhanced eus and eus elasticity imaging in the diagnosis of pancreatic solid masses" src="slide2.swf" size="1618" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset1" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="8.4389996"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Contrast-enhanced EUS 
and 
EUS elasticity imaging 
in the diagnosis of pancreatic solid masses
Yoshiki Hirooka
Professor and Chairman, 
Fujita Health University School of Medicine, 
Department of liver, biliary tract and pancreas diseases.</text>
		</slide>
		<slide index="2" title="Contrast-enhanced EUS and EUS elasticity imaging in the diagnosis of pancreatic solid masses" titleNormalized="contrast-enhanced eus and eus elasticity imaging in the diagnosis of pancreatic solid masses" src="slide3.swf" size="1549" advanceOnTime="1" framesCount="126" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset2" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="125" playTime="5.2083333" pauseTime="1.5616666"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Contrast-enhanced EUS 
and 
EUS elasticity imaging 
in the diagnosis of pancreatic solid masses</text>
		</slide>
		<slide index="3" title="" titleNormalized="" src="slide4.swf" size="225607" advanceOnTime="1" framesCount="611" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset3" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="610" playTime="25.4166667" pauseTime="8.0833333"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Intra-arterial injection 
of 
carbon dioxide (CO2)
Hirooka Y et al. J Gastroenterol 2012; 47: 1063-1072.</text>
		</slide>
		<slide index="4" title="" titleNormalized="" src="slide5.swf" size="151320" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset4" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="14.9140000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Hirooka Y et al. J Gastroenterol 2012; 47: 1063-1072.</text>
		</slide>
		<slide index="5" title="" titleNormalized="" src="slide6.swf" size="129051" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset5" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="12.7780003"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Multiphase Evaluation of Contrast-enhanced Endoscopic Ultrasonography in the Diagnosis of Pancreatic Solid Lesions</text>
		</slide>
		<slide index="6" title="We reported the usefulness of Time-intensity curve (TIC) under contrast-enhanced EUS (CE-EUS)." titleNormalized="we reported the usefulness of time-intensity curve (tic) under contrast-enhanced eus (ce-eus)." src="slide7.swf" size="36885" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset6" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.2189993"/>
			</animationSteps>
			<notes>我々は造影超音波内視鏡、CE-EUS 下でTime-intensity curve (TIC) を作成することによる膵病変診断における有用性を報告してきました。これまでの検討でエコー輝度の一分間でのピーク値からの減少率において膵癌とその他の疾患で有意な差があることがわかっています。過去の報告では減少率35%をカットオフ値とすると膵癌に対する感度、特異度、正診率はそれぞれ87.5%、88.9%、88.0%となっています。</notes>
			<notesNormalized>我々は造影超音波内視鏡、ce-eus 下でtime-intensity curve (tic) を作成することによる膵病変診断における有用性を報告してきました。これまでの検討でエコー輝度の一分間でのピーク値からの減少率において膵癌とその他の疾患で有意な差があることがわかっています。過去の報告では減少率35%をカットオフ値とすると膵癌に対する感度、特異度、正診率はそれぞれ87.5%、88.9%、88.0%となっています。</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;我々は造影超音波内視鏡、CE-EUS 下でTime-intensity curve (TIC) を作成することによる膵病変診断における有用性を報告してきました。これまでの検討でエコー輝度の一分間でのピーク値からの減少率において膵癌とその他の疾患で有意な差があることがわかっています。過去の報告では減少率35%をカットオフ値とすると膵癌に対する感度、特異度、正診率はそれぞれ87.5%、88.9%、88.0%となっています。&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Singnificant differences were noted in the echo intensity (EI) reduction rate relative to the peak at 1 minute
We reported the usefulness of Time-intensity curve (TIC) under 
contrast-enhanced EUS (CE-EUS).
EI reduction rate =
I peak – I t1
I peak
Diagnostic accuracy
*
*considering 35% of EI reduction rate at one minute as a cutoff value
Matsubara H, Hirooka Y et al. Pancreas 2011; 40: 1073-9</text>
		</slide>
		<slide index="7" title="One-minute-continuous observation of CE-EUS for pancreatic lesions" titleNormalized="one-minute-continuous observation of ce-eus for pancreatic lesions" src="slide8.swf" size="148177" advanceOnTime="1" framesCount="351" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset7" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="350" playTime="14.5833333" pauseTime="17.0866667"/>
			</animationSteps>
			<notes>実際の動画をお示しします。左は浸潤型膵管癌IDC、右は膵内分泌腫瘍PNENの画像になります。IDCでは造影剤注入後10秒ほどで早期に濃染を認めますが、その後すみやかにエコー輝度の低下を認め20秒後ほどで乏血性となります。一方、NENでは造影剤注入後速やかに造影され、一分後まで造影効果が持続しています。TICを作成すると下図のようになり、両者での造影様式の違いは一目瞭然です。このようにTICを作成することで関心領域の連続的および定量的評価が可能となりますが、TICを作成できる装置は限られており、手技も煩雑なため、TICによる評価は必ずしも容易ではありません。</notes>
			<notesNormalized>実際の動画をお示しします。左は浸潤型膵管癌idc、右は膵内分泌腫瘍pnenの画像になります。idcでは造影剤注入後10秒ほどで早期に濃染を認めますが、その後すみやかにエコー輝度の低下を認め20秒後ほどで乏血性となります。一方、nenでは造影剤注入後速やかに造影され、一分後まで造影効果が持続しています。ticを作成すると下図のようになり、両者での造影様式の違いは一目瞭然です。このようにticを作成することで関心領域の連続的および定量的評価が可能となりますが、ticを作成できる装置は限られており、手技も煩雑なため、ticによる評価は必ずしも容易ではありません。</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;実際の動画をお示しします。左は浸潤型膵管癌IDC、右は膵内分泌腫瘍PNENの画像になります。IDCでは造影剤注入後10秒ほどで早期に濃染を認めますが、その後すみやかにエコー輝度の低下を認め20秒後ほどで乏血性となります。一方、NENでは造影剤注入後速やかに造影され、一分後まで造影効果が持続しています。TICを作成すると下図のようになり、両者での造影様式の違いは一目瞭然です。このようにTICを作成することで関心領域の連続的および定量的評価が可能となりますが、TICを作成できる装置は限られており、手技も煩雑なため、TICによる評価は必ずしも容易ではありません。&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>One-minute-continuous observation of CE-EUS for pancreatic lesions
Invasive ductal cancer (IDC)
Neuroendocrine neoplasm (NEN)
Time Intensity Curve
0
20
40
60
(sec)
0
20
40
60
(sec)
100
200
(level)
100
200
(level)
Time-intensity curve allows continuous and quantitative evaluation of enhancement pattern in the targeted area. However, TIC is only available in specific devices and the process is somewhat complicated.</text>
		</slide>
		<slide index="8" title="Objective" titleNormalized="objective" src="slide9.swf" size="1291" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset8" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="14.7490000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Objective
We aimed to propose a simplified method by evaluating multiple phases of CE-EUS in the diagnosis of pancreatic solid lesions.</text>
		</slide>
		<slide index="9" title="Patients" titleNormalized="patients" src="slide10.swf" size="3448" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset9" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.9889998"/>
			</animationSteps>
			<notes>2006年1月から2016年12月までに当院でSonazoid®を用いた造影ハーモニック法にてCE-EUSを行った症例のうち、最終診断が得られた膵充実性病変210例を対象としました。男女比は127: 83、年齢の中央値は66.5歳でした。疾患の内訳はIDC142例、PNEN 31例、充実性偽乳頭状腫瘍 (SPN) 13例、腫瘤形成性膵炎 (MFP) 24例でした。腫瘍性病変186例は全例手術により病理組織学的診断を得ており、良性疾患24例はEUS-FNAにて悪性除外した後、1年以上の経過観察にて診断しています。尚良性疾患24例中20例は限局型の自己免疫性膵炎と診断されました。</notes>
			<notesNormalized>2006年1月から2016年12月までに当院でsonazoid®を用いた造影ハーモニック法にてce-eusを行った症例のうち、最終診断が得られた膵充実性病変210例を対象としました。男女比は127: 83、年齢の中央値は66.5歳でした。疾患の内訳はidc142例、pnen 31例、充実性偽乳頭状腫瘍 (spn) 13例、腫瘤形成性膵炎 (mfp) 24例でした。腫瘍性病変186例は全例手術により病理組織学的診断を得ており、良性疾患24例はeus-fnaにて悪性除外した後、1年以上の経過観察にて診断しています。尚良性疾患24例中20例は限局型の自己免疫性膵炎と診断されました。</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;2006年1月から2016年12月までに当院でSonazoid®を用いた造影ハーモニック法にてCE-EUSを行った症例のうち、最終診断が得られた膵充実性病変210例を対象としました。男女比は127: 83、年齢の中央値は66.5歳でした。疾患の内訳はIDC142例、PNEN 31例、充実性偽乳頭状腫瘍 (SPN) 13例、腫瘤形成性膵炎 (MFP) 24例でした。腫瘍性病変186例は全例手術により病理組織学的診断を得ており、良性疾患24例はEUS-FNAにて悪性除外した後、1年以上の経過観察にて診断しています。尚良性疾患24例中20例は限局型の自己免疫性膵炎と診断されました。&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Patients with pancreatic solid lesions 
(n = 210)
Contrast-enhanced EUS (n = 210)
Surgery (n = 186)
EUS-FNA (n = 24)
IDC
(n = 142)
PNEN
(n = 31)
SPN
(n = 13)
MFP
(n = 24)
AIP
(n = 20)
Patients
127 men
83 women
Median age 66.5 
Between Jan 2006 and Dec 2016
IDC: Invasive ductal cancer, PNEN: Pancreatic neuroendocrine neoplasm, SPN: Solid-pseudopapillary neoplasm,
AIP: Autoimmune pancreatitis, MFP: Mass forming pancreatitis
Follow-up &gt; one year</text>
		</slide>
		<slide index="10" title="Multiphase evaluation of CE-EUS" titleNormalized="multiphase evaluation of ce-eus" src="slide11.swf" size="15992" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset10" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="25.3590006"/>
			</animationSteps>
			<notes>Each image at 20, 40, 60 seconds was used for the evaluation.</notes>
			<notesNormalized>each image at 20, 40, 60 seconds was used for the evaluation.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Each image at 20, 40, 60 seconds was used for the evaluation.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Description　 　 + 　　　 0 　　　　 -
hyper
iso
hypo
Intensity
Time (sec)
20
60
40
Target lesion
Surrounding pancreas
Multiphase evaluation of CE-EUS</text>
		</slide>
		<slide index="11" title="Enhancement patterns in the invasive ductal cancers" titleNormalized="enhancement patterns in the invasive ductal cancers" src="slide12.swf" size="12803" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset11" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.4490008"/>
			</animationSteps>
			<notes>膵癌群では大半の症例が20秒以内にエコー輝度の減弱を認めており、142例中118例 83% においては20秒または40秒で、hypovascularパターンを示しました。</notes>
			<notesNormalized>膵癌群では大半の症例が20秒以内にエコー輝度の減弱を認めており、142例中118例 83% においては20秒または40秒で、hypovascularパターンを示しました。</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;膵癌群では大半の症例が20秒以内にエコー輝度の減弱を認めており、142例中118例 83% においては20秒または40秒で、hypovascularパターンを示しました。&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>-/-/-
102/142 
(71.8%)
-/0/0
11/142 
(7.7%)
0/-/-
3/142 
(2.1%)
-/-/0
2/142 
(1.4%)
Others
24/142
(16.9%)
0/-/-
-/0/0
Others
-/-/-
-/-/0
118/142
83%
Enhancement patterns in the invasive ductal cancers</text>
		</slide>
		<slide index="12" title="Enhancement patterns in the pancreatic neuroendocrine neoplasms and solid pseudopapillary neoplasms" titleNormalized="enhancement patterns in the pancreatic neuroendocrine neoplasms and solid pseudopapillary neoplasms" src="slide13.swf" size="12819" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset12" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="26.3289999"/>
			</animationSteps>
			<notes>神経内分泌腫瘍とSPN群では持続的なhypervascularパターンが多くみられました。44例中18例 41%では3相ともにhyperとなり、27例 61.3%では20秒または40秒いずれかでhypervascularとなりました。尚、本研究では術前の画像診断で形態が類似し鑑別が容易ではないPNENとSPNを同一グループとして評価しています。</notes>
			<notesNormalized>神経内分泌腫瘍とspn群では持続的なhypervascularパターンが多くみられました。44例中18例 41%では3相ともにhyperとなり、27例 61.3%では20秒または40秒いずれかでhypervascularとなりました。尚、本研究では術前の画像診断で形態が類似し鑑別が容易ではないpnenとspnを同一グループとして評価しています。</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;神経内分泌腫瘍とSPN群では持続的なhypervascularパターンが多くみられました。44例中18例 41%では3相ともにhyperとなり、27例 61.3%では20秒または40秒いずれかでhypervascularとなりました。尚、本研究では術前の画像診断で形態が類似し鑑別が容易ではないPNENとSPNを同一グループとして評価しています。&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>+/+/+
+/0/0
Others
+/+/+
18/44
(41.0%)
+/0/0
5/44 
(11.3%)
+/+/0
3/44 
(6.7%)
+/0/-
1/44 
(2.3%)
Others
17/44
(38.7%)
+/+/0
+/0/-
Enhancement patterns in the 
pancreatic neuroendocrine neoplasms and solid pseudopapillary neoplasms
27/44
61.3%</text>
		</slide>
		<slide index="13" title="Diagnostic accuracy of multiphase CE-EUS for pancreatic cancer" titleNormalized="diagnostic accuracy of multiphase ce-eus for pancreatic cancer" src="slide14.swf" size="3813" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset13" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="25.3590006"/>
			</animationSteps>
			<notes>以上の結果を踏まえて、20秒または40秒の時点でhypovascular patternを示すものを膵癌パターンとすると、膵癌に対する感度、特異度および正診率は、それぞれ83.1％、86.8％および84.3％となり、いずれか1相のみの評価よりも高い診断能を示しました。</notes>
			<notesNormalized>以上の結果を踏まえて、20秒または40秒の時点でhypovascular patternを示すものを膵癌パターンとすると、膵癌に対する感度、特異度および正診率は、それぞれ83.1％、86.8％および84.3％となり、いずれか1相のみの評価よりも高い診断能を示しました。</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;以上の結果を踏まえて、20秒または40秒の時点でhypovascular patternを示すものを膵癌パターンとすると、膵癌に対する感度、特異度および正診率は、それぞれ83.1％、86.8％および84.3％となり、いずれか1相のみの評価よりも高い診断能を示しました。&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Vascular patterns
Sensitivity
Specificity
Accuracy
(-/any/any) or (any/-/any)
83.1%
86.8%
84.3%
(-/any/any)
81.0%
88.2%
83.3%
(any/-/any)
75.4%
92.7%
81.0%
(any/any/-)
78.2%
83.8%
80.0%
(-/any/any): Showing hypovascular pattern at 20 seconds among three phases
(any/-/any): Showing hypovascular pattern at 40 seconds among three phases
(any/any/-): Showing hypovascular pattern at 60 seconds among three phases
Diagnostic accuracy of multiphase CE-EUS for pancreatic cancer</text>
		</slide>
		<slide index="14" title="Comparison between TIC and multiphase evaluation" titleNormalized="comparison between tic and multiphase evaluation" src="slide15.swf" size="3931" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset14" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="14.2789997"/>
			</animationSteps>
			<notes>TICと多相評価法の比較です。膵病変210例中73例においてTICを作成していますが、reduction rate が35%より大きいものを膵癌とした場合、感度、特異度、正診率はそれぞれ86.7%、88.9%、87.7%となりました。またTICと多相評価両方が可能であった浸潤性膵管癌30例についてみてみますと26例で診断が一致していました。</notes>
			<notesNormalized>ticと多相評価法の比較です。膵病変210例中73例においてticを作成していますが、reduction rate が35%より大きいものを膵癌とした場合、感度、特異度、正診率はそれぞれ86.7%、88.9%、87.7%となりました。またticと多相評価両方が可能であった浸潤性膵管癌30例についてみてみますと26例で診断が一致していました。</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;TICと多相評価法の比較です。膵病変210例中73例においてTICを作成していますが、reduction rate が35%より大きいものを膵癌とした場合、感度、特異度、正診率はそれぞれ86.7%、88.9%、87.7%となりました。またTICと多相評価両方が可能であった浸潤性膵管癌30例についてみてみますと26例で診断が一致していました。&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Comparison between TIC and multiphase evaluation
In 73 out of 210 cases (30 with IDC, 16 with PNEN and 27 with MFP), TIC was created.
TIC
(N = 73)
EI reduction rate &gt; 35%
Multiphase evaluation
(N = 210)
(-) at either 20 or 40 sec
Sensitivity
86.7%
83.1%
Specificity
88.9%
86.8%
Accuracy
87.7%
84.3%</text>
		</slide>
		<slide index="15" title="Summary and Conclusion" titleNormalized="summary and conclusion" src="slide16.swf" size="2688" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset15" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="33.0289988"/>
			</animationSteps>
			<notes>まとめです。CE-EUS多相評価において20秒または40秒でhypovascularとなるものを膵癌パターンとした場合、膵癌に対する感度、特異度、正診率は83.1%、86.8%、84.3%で、1相のみの評価より高い診断能を示しました。病理組織学的な検討では組織型、INF、神経浸潤において膵癌パターンを示したものとそうでないもので有意差を認めました。</notes>
			<notesNormalized>まとめです。ce-eus多相評価において20秒または40秒でhypovascularとなるものを膵癌パターンとした場合、膵癌に対する感度、特異度、正診率は83.1%、86.8%、84.3%で、1相のみの評価より高い診断能を示しました。病理組織学的な検討では組織型、inf、神経浸潤において膵癌パターンを示したものとそうでないもので有意差を認めました。</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;まとめです。CE-EUS多相評価において20秒または40秒でhypovascularとなるものを膵癌パターンとした場合、膵癌に対する感度、特異度、正診率は83.1%、86.8%、84.3%で、1相のみの評価より高い診断能を示しました。病理組織学的な検討では組織型、INF、神経浸潤において膵癌パターンを示したものとそうでないもので有意差を認めました。&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Summary and Conclusion
Considering those showing hypovascular pattern at 20 or 40 seconds as an IDC pattern, the sensitivity, specificity and accuracy for pancreatic cancer was 83.1％、86.8％ and 84.3％, respectively (which was higher than that of single phase evaluation).

Multiphase evaluation of CE-EUS is a convenient and useful method for the differentiation of pancreatic solid lesions which can be alternatively used for TIC evaluation.</text>
		</slide>
		<slide index="16" title="Contrast-enhanced EUS and EUS elasticity imaging in the diagnosis of pancreatic solid masses" titleNormalized="contrast-enhanced eus and eus elasticity imaging in the diagnosis of pancreatic solid masses" src="slide17.swf" size="1552" advanceOnTime="1" framesCount="132" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset16" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="131" playTime="5.4583333" pauseTime="0.7816664"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Contrast-enhanced EUS 
and 
EUS elasticity imaging 
in the diagnosis of pancreatic solid masses</text>
		</slide>
		<slide index="17" title="" titleNormalized="" src="slide18.swf" size="85310" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset17" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="11.2439999"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>JSUM: The Japan Society of Ultrasonics in Medicine</text>
		</slide>
		<slide index="18" title="Elastography classification" titleNormalized="elastography classification" src="slide19.swf" size="112754" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset18" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="25.2590002"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Elastography classification</text>
		</slide>
		<slide index="19" title="Principle of Strain Elastography" titleNormalized="principle of strain elastography" src="slide20.swf" size="199103" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset19" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="58.7589983"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>B mode image
Elastography image
Principle of Strain Elastography
Hard lesion
Soft lesion
【Methods of Interpretation】
 Pattern recognition
 Strain ratio
 Strain Histogram
Measurement of relative stiffness
A principle of elastography is explained by one dimension spring model which is connected in a line of soft and hard springs. When this spring model is compressed, a difference occurs in variation between these springs, and information of elasticity as distortion is obtained by space differentiation of these variation.</text>
		</slide>
		<slide index="20" title="Principle of Shear wave elastography (SW)" titleNormalized="principle of shear wave elastography (sw)" src="slide21.swf" size="130404" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset20" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="24.7590002"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="21" title="Feasibility study of EUS-SWM for pancreas" titleNormalized="feasibility study of eus-swm for pancreas" src="slide22.swf" size="187602" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset21" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="9.2389998"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Feasibility study of EUS-SWM for pancreas
 In this study, we first evaluated the feasibility of a newly developed EUS shear‑wave measurement (EUS‑SWM).</text>
		</slide>
		<slide index="22" title="" titleNormalized="" src="slide23.swf" size="166512" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset22" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.3480000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="23" title="Comparison of pancreatic elasticity between AIP cases and the normal controls" titleNormalized="comparison of pancreatic elasticity between aip cases and the normal controls" src="slide24.swf" size="53540" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset23" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="11.7090000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Comparison of pancreatic elasticity between AIP cases and the normal controls
Comparison of median Vs between AIP cases and the normal controls.


For AIP patients who underwent steroid therapy, median Vs , serum IgG4 level and pancreatic size were compared before and 2 weeks after steroid therapy.
①
②
Normal control
AIP (before steroid Tx.)
AIP (after steroid Tx.)</text>
		</slide>
		<slide index="24" title="" titleNormalized="" src="slide25.swf" size="2746" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset24" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.5859999"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS guided shear-wave measurement
N=160
Dec.2017 to Sep.2018
Normal pancreas 
or
Diffuse pancreatic lesion
N=51
Focal pancreatic lesion
N=109
Normal pancreas
N=16
Autoimmune pancreatitis
N=14
* In 6 cases, EUS-SWM was performed twice.
(Before and after steroid therapy)</text>
		</slide>
		<slide index="25" title="Shear-wave velocity(Vs) in the pancreas" titleNormalized="shear-wave velocity(vs) in the pancreas" src="slide26.swf" size="5259" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset25" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="16.1489996"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Normal control
(N=16)
1.89m/s
(IQR: 1.68-2.63)
Autoimmune pancreatitis
(N=14)
2.57m/s
(IQR: 2.16-3.08)
P=0.0185
 Median Vs 
Shear-wave velocity(Vs) in the pancreas
(m/s)
The median elasticity of AIP patients was significantly higher than that of normal control. 
 Mann-Whitney U test</text>
		</slide>
		<slide index="26" title="The changes of the elasticity of the pancreas(Vs) before and after the steroid treatment" titleNormalized="the changes of the elasticity of the pancreas(vs) before and after the steroid treatment" src="slide27.swf" size="10532" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset26" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="12.8090004"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Median Vs (m/s)
Before steroid therapy
N=6
3.32 m/s
(IQR: 2.93-3.59)
After steroid therapy
N=6
2.46 m/s
(1.84-2.96)
P=0.0234
The changes of the elasticity of the pancreas(Vs) before and after the steroid treatment
Wilcoxon signed-rank test</text>
		</slide>
		<slide index="27" title="Summary" titleNormalized="summary" src="slide28.swf" size="1737" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset27" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="21.6190008"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Summary
①EUS-SWM is a feasible technique for measurement of elasticity of the pancreas 

Success rate of EUS-SWM was 97.6%.
The median Vs of the pancreas was 2.21 m/s.
The median reliability index(VsN) for measurement of the pancreas was 74%.



②The elasticity of the pancreas parenchyma in AIP cases was significantly higher than that in normal control.


③For AIP cases, the median Vs significantly decreased after steroid therapy.
</text>
		</slide>
		<slide index="28" title="Elastography classification" titleNormalized="elastography classification" src="slide29.swf" size="113194" advanceOnTime="1" framesCount="213" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset28" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="212" playTime="8.8333333" pauseTime="0.9466664"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Elastography classification
EUS elasticity imaging</text>
		</slide>
		<slide index="29" title="" titleNormalized="" src="slide30.swf" size="135759" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset29" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="23.4560007"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="30" title="Conclusion" titleNormalized="conclusion" src="slide31.swf" size="1906" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset30" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.6890005"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Contrast-enhanced EUS and EUS elasticity imaging provide a useful information different from each other.

How and When to use those modalities needs to be further discussed.
Conclusion</text>
		</slide>
	</slides>
</presentation>
